Effects of neoadjuvant chemotherapy for patients with obstructive colon cancer: A multicenter propensity score-matched analysis (YCOG2101).

Ann Gastroenterol Surg · 2024 · PMC10914701 · PMID 38455492

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

The FOxTROT trial demonstrated a significant decrease in the R1 resection rate and a nonsignificant trend toward better oncological outcomes at 2 years. 14 However, only a few patients in the FOxTROT trial had colonic obstructions (2.7%).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.